tiprankstipranks
Research Solutions Inc (RSSS)
NASDAQ:RSSS
Want to see RSSS full AI Analyst Report?

Research Solutions (RSSS) AI Stock Analysis

160 Followers

Top Page

RSSS

Research Solutions

(NASDAQ:RSSS)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
$2.50
▼(-16.67% Downside)
Action:Reiterated
Date:05/19/26
The score is driven primarily by strong financial quality (debt-free balance sheet, improved profitability, and solid cash conversion). This is meaningfully offset by weak technicals (price below key moving averages) and a mixed earnings-call outlook where ARR/platform momentum and margin gains are tempered by expected ongoing transaction revenue pressure and B2C competition, with valuation remaining mid-range (P/E ~20.8, no dividend yield provided).
Positive Factors
Debt-free balance sheet
Zero debt materially lowers financial risk and interest burden, giving management durable flexibility to fund product investments, absorb churn-related cash swings, and pay remaining site earn-outs from operations. This supports long-term resilience and optionality for M&A or reinvestment.
Negative Factors
Top-line stagnation
Flat-to-slightly negative revenue growth undermines scalability of margin gains and raises questions about demand momentum. Without durable revenue growth, margin improvements and cash flow gains may be hard to sustain and heighten dependence on upsells and cost discipline.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
Zero debt materially lowers financial risk and interest burden, giving management durable flexibility to fund product investments, absorb churn-related cash swings, and pay remaining site earn-outs from operations. This supports long-term resilience and optionality for M&A or reinvestment.
Read all positive factors

Research Solutions (RSSS) vs. SPDR S&P 500 ETF (SPY)

Research Solutions Business Overview & Revenue Model

Company Description
Research Solutions (RSSS) is a technology company that provides cloud-based software solutions aimed at simplifying the process of accessing and managing scientific, technical, and medical (STM) content. The company operates primarily in the infor...
How the Company Makes Money
Research Solutions generates revenue primarily from (1) technology platform and subscription-based offerings and (2) transaction-based fulfillment of research content. On the platform side, the company sells recurring subscriptions/SaaS-style acce...

Research Solutions Earnings Call Summary

Earnings Call Date:Feb 12, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:Sep 17, 2026
Earnings Call Sentiment Positive
The call presented a mix of strong operational and financial improvements (ARR +14%, platform subscription revenue +14%, adjusted EBITDA +36%, margin expansion, positive net income and improved cash flow) alongside continuing top-line pressure in transaction/document delivery and B2C channels driven by a churned large account, lower trial-to-subscriber conversion, and increased competition. Management emphasized strategic progress—API/AI integrations, infrastructure deals with much higher ASPs, and product investments—that underpin durable, higher-margin growth, while acknowledging near-term revenue and pricing execution risks related to transaction dynamics and evolving API pricing models.
Positive Updates
ARR Growth and Platform Strength
Annual recurring revenue (ARR) ended the quarter at $21.8M, up 14% year-over-year; B2B ARR ~ $15.3M and normalized B2C ARR ~ $6.4M. Platform revenue share rose to 44% of total revenue from 39% a year ago (≈+500 bps).
Negative Updates
Overall Revenue Essentially Flat / Slight Decline
Total revenue was $11.8M versus $11.9M in the prior-year quarter (≈-0.8%), indicating top-line pressure despite platform growth.
Read all updates
Q2-2026 Updates
Negative
ARR Growth and Platform Strength
Annual recurring revenue (ARR) ended the quarter at $21.8M, up 14% year-over-year; B2B ARR ~ $15.3M and normalized B2C ARR ~ $6.4M. Platform revenue share rose to 44% of total revenue from 39% a year ago (≈+500 bps).
Read all positive updates
Company Guidance
Management said transaction revenue weakness (Q2 transaction revenue $6.6M vs $7.3M LY)—driven largely by one churned account—is expected to persist into the second half and B2C will face continued competition, while B2B is the primary growth driver: ARR finished Q2 at $21.8M (+14% YoY) including roughly $15.3M of B2B ARR and $6.4M of normalized B2C ARR, platform subscription revenue rose to ~$5.2M (+~14%), total incremental ARR was $560K (the largest organic Q2), 47 net new platform deployments were added and ASP increased 6%; management reiterated a goal to return SaaS growth to 20%+, to exceed fiscal 2025 EBITDA levels in each remaining quarter (Q3/Q4 are typically strongest), to grow cash flow (Q2 cash from operations $1.4M, +35%) while funding remaining site earn-outs from operations, and to exit the year with stronger earnings, cash generation and balance-sheet flexibility (cash $12.3M, no revolver borrowings).

Research Solutions Financial Statement Overview

Summary
Strong financial health supported by a debt-free balance sheet (zero debt) and meaningfully improved profitability (TTM net margin ~9.3% with stronger gross margins ~50.7%). Cash conversion is solid (FCF to net income ~0.99), but the TTM revenue decline (~-1.1%) and a sharp recent drop in free cash flow (~-24.8%) temper the score.
Income Statement
71
Positive
Balance Sheet
88
Very Positive
Cash Flow
74
Positive
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue48.66M49.06M44.62M37.70M32.93M31.76M
Gross Profit24.38M24.20M19.64M14.70M12.02M10.29M
EBITDA6.23M3.54M88.12K169.30K-1.47M-235.14K
Net Income4.52M1.27M-3.79M571.62K-1.63M-285.09K
Balance Sheet
Total Assets45.95M46.12M41.86M21.83M17.03M16.92M
Cash, Cash Equivalents and Short-Term Investments12.05M12.23M6.10M13.55M10.60M11.00M
Total Debt0.000.000.000.000.000.00
Total Liabilities26.89M32.19M30.17M14.50M12.14M11.49M
Stockholders Equity19.06M13.93M11.69M7.33M4.88M5.43M
Cash Flow
Free Cash Flow5.72M7.00M3.48M3.34M-461.49K1.85M
Operating Cash Flow5.76M7.02M3.55M3.38M-417.20K1.87M
Investing Cash Flow-36.30K-19.26K-10.10M-344.66K-44.29K-19.85K
Financing Cash Flow-3.53M-877.88K-905.85K-97.26K63.27K-159.97K

Research Solutions Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.00
Price Trends
50DMA
2.40
Negative
100DMA
2.48
Negative
200DMA
2.83
Negative
Market Momentum
MACD
-0.08
Positive
RSI
42.95
Neutral
STOCH
27.92
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RSSS, the sentiment is Negative. The current price of 3 is above the 20-day moving average (MA) of 2.34, above the 50-day MA of 2.40, and above the 200-day MA of 2.83, indicating a bearish trend. The MACD of -0.08 indicates Positive momentum. The RSI at 42.95 is Neutral, neither overbought nor oversold. The STOCH value of 27.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RSSS.

Research Solutions Risk Analysis

Research Solutions disclosed 31 risk factors in its most recent earnings report. Research Solutions reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Research Solutions Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$71.91M15.4727.45%-0.18%
63
Neutral
$87.49M37.9811.26%15.26%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
58
Neutral
$113.80M-5.29-15.26%-1.25%-109.14%
55
Neutral
$404.96M-28.37-21.46%122.12%45.07%
50
Neutral
$98.06M-6.54-20.76%-4.78%-90.32%
44
Neutral
$27.46M-1.18-97.07%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RSSS
Research Solutions
2.21
-0.62
-21.91%
IDN
Intellicheck Mobilisia
4.18
-1.35
-24.41%
SSTI
SoundThinking Inc
7.60
-8.32
-52.26%
DUOT
Duos Technologies Group
13.51
5.35
65.56%
EXFY
Expensify
1.16
-1.13
-49.34%
YXT
YXT.COM Group Holding Limited Sponsored ADR
0.44
-0.43
-49.48%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 19, 2026